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Abstract: The oral bioavailability of many hydrophobic bioactive compounds found in natural food
products (such as vitamins and nutraceuticals in fruits and vegetables) is relatively low due to their
low bioaccessibility, chemical instability, or poor absorption. Most previous research has therefore
focused on the design of delivery systems to incorporate isolated bioactive compounds into food
products. However, a more sustainable and cost-effect approach to enhancing the functionality
of bioactive compounds is to leave them within their natural environment, but specifically design
excipient foods that enhance their bioavailability. Excipient foods typically do not have functionality
themselves but they have the capacity to enhance the functionality of nutrients present in natural
foods by altering their bioaccessibility, absorption, and/or chemical transformation. In this review
article we present the use of excipient nanoemulsions for increasing the bioavailability of bioactive
components from fruits and vegetables. Nanoemulsions present several advantages over other food
systems for this application, such as the ability to incorporate hydrophilic, amphiphilic, and lipophilic
excipient ingredients, high physical stability, and rapid gastrointestinal digestibility. The design,
fabrication, and application of nanoemulsions as excipient foods will therefore be described in
this article.
Keywords: excipient; nanoemulsions; bioactive; delivery; functional; oral bioavailability

1. Introduction
1.1. Concept of Excipient Foods
The functionality of bioactive compounds present in foods, dietary supplements, or drugs largely
depends on their fate in the gastrointestinal tract (GIT). The bioavailability of many health-promoting
compounds is generally low due to their low bioaccessibility, susceptibility to degradation, or poor
absorption profile. The processes that govern the oral bioavailability of bioactive compounds are
complex and include liberation of the bioactive from the ingested drug, supplement, or food [1];
solubilization within gastrointestinal fluids [2,3]; transport into or out of epithelial cells [4,5]; and/or,
biochemical or chemical transformations [6,7]. In this article, we focus on enhancing the bioavailability
of lipophilic bioactive compounds found in foods (particularly fruits and vegetables), but the same
principles could also be applied to supplements and pharmaceuticals. There is strong evidence
that the nature of foods influences the bioavailability of co-ingested bioactive compounds, thereby
altering their bioactivity. The ingredients present in the food matrix might favor or inhibit the
liberation and solubilization of functional compounds during digestion [8,9]. Therefore, there is an
Nanomaterials 2016, 6, 17; doi:10.3390/nano6010017
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opportunity to optimize the formulation of food products to improve the bioavailability of bioactive
compounds. There are several strategies that can be used to enhance the liberation, solubilization and
absorption of bioactive compounds. Colloidal delivery systems can be used to incorporate isolated
lipophilic bioactive ingredients into food products, such as nanoemulsions, emulsions, or solid lipid
nanoparticles [10,11]. In this case, the bioactive compound is first extracted from a natural source and
it is then solubilized in a lipid phase prior to the formation of the colloidal delivery system that will
be ultimately incorporated in a food product. Alternatively, the bioactive compounds might be left
in their natural source (fruit or vegetable) and consumed along with a specific formulation able to
boost their bioactivity. In this context, the concept of excipient foods has been introduced as foods that
are specifically designed to improve the bioavailability of bioactive components [12]. Excipient foods
might or might not have an intrinsic bioactivity themselves, but when they co-ingested with other
foods they can boost the bioactivity of any bioactive compounds present.
1.2. Nanoemulsions as Excipient Foods
Nanoemulsions have been described as excellent carriers for lipophilic bioactive compounds with
enhanced properties compared to conventional emulsions. Typically, nanoemulsions are defined as
oil-in-water emulsions with a very small droplet size (r < 100 nm). Their small droplet dimensions
confer them with unique properties, such as improved physical stability, high optical clarity, and
enhanced bioavailability [13]. Due to their small droplet size, nanoemulsions have a large surface area
and can therefore interact strongly with biological components in the GIT. For instance, nanoemulsions
typically have a higher digestion rate in the gastrointestinal tract compared to conventional emulsions
since they have more binding sites available for digestive enzymes, such as lipase [14]. Moreover,
the small droplet size may favor the rapid transfer of naturally occurring hydrophobic bioactives
present in foods into the oil droplets. Thus, in this review article, we focus on describing the use
of nanoemulsions as excipient foods and how their composition and structure can be modulated to
achieve an optimal efficacy of the functional components of natural food products.
2. Excipient Foods
The relationship between the composition of foods and many health issues is well documented and
consumers are nowadays generally aware of the importance of a balanced diet. However, the lifestyle
of many modern consumers makes it difficult to ingest all of the nutrients needed to maintain normal
body functions or promote good health. The use of food products or nutraceuticals to treat health
conditions has already been described and is intended to prevent or cure certain diseases. Medical or
functional foods fall in the category of foods that are specifically designed to ameliorate human health
problems [15]. For instance, a medical food is defined by the Food and Drug Administration (FDA) as
“a food which is formulated to be consumed or administered entirely under the supervision of a physician and
which is intended for the specific dietary management of a disease or condition for which distinctive nutritional
requirements, based on recognized scientific principles, are established by medical evaluation” [15]. On the
other hand, functional foods are described as natural or processed foods that have been specifically
been fortified with bioactive compounds. Various types of functional food products already exist
in the market, such as milks fortified with vitamin D, orange juices enriched with calcium, yogurts
containing probiotics, spreads fortified with phytosterols, and breakfast cereals containing ω-3 fatty
acids, vitamins, and minerals [16]. Nevertheless, the concept of designing healthier food products has
recently gone a step further to optimize the promotion of the intrinsic health properties of natural food
products. In this context, excipient foods have been introduced as foods that are able to improve the
bioactivity of foods co-ingested with them [12] (Figure 1). Thus, excipient foods do not necessarily have
bioactive properties but when ingested along with natural or processed food products they are able to
promote the release and absorption of naturally occurring bioactive compounds. Excipient foods can
be classified into two groups: (i) integrated excipient foods—the bioactive agents are dispersed into
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the excipient food formulation; (ii) non-integrated excipient foods—a bioactive-rich food is co-ingested
with
an excipient
food
Nanomaterials
2016, 6,
17 formulation (Figure 1).
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Figure 1. Schematic diagram of the difference between integrated and non-integrated excipient foods.
Figure 1. Schematic diagram of the difference between integrated and non-integrated excipient foods.
For integrated excipient foods the bioactive component (pharmaceutical or nutraceutical) is dispersed
For integrated excipient foods the bioactive component (pharmaceutical or nutraceutical) is dispersed
within the excipient food matrix, but for non-integrated excipient foods the bioactive component is in
within the excipient food matrix, but for non-integrated excipient foods the bioactive component is in
another product that is co-ingested with the excipient food.
another product that is co-ingested with the excipient food.
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Table 1. Examples of potential excipient foods to be co-ingested with natural food products to
enhance the oral bioavailability of bioactive compounds.
Table 1. Examples of potential excipient foods to be co-ingested with natural food products to enhance
Food
Source
Excipient Food
Bioactive Compound
the oral
bioavailability
of Compatible
bioactive compounds.

Salad
FruitsFood
and berries
Source
Salad
Vegetables
Fruits and berries

Nuts and seeds
Vegetables
Meat
Nuts
and seeds
Dairy
products
Meat
(cheese)
Dairy products (cheese)
Fish
Fish

Salad dressing
Carotenoids
Cream,
ice cream,
yogurtFood Flavonoids,
vitamins,
coenzyme Q10
Compatible
Excipient
Bioactive
Compound
Carotenoids,
vitamins,
Salad dressing
Carotenoids
Edible coatings,
sauce
phytosterols/stanols
Cream, ice cream, yogurt
Flavonoids,
vitamins, coenzyme Q10
Carotenoids,vitamins
vitamins,
Edible coatings, sauce
Flavonoids,
Edible coatings, sauce
phytosterols/stanols
Sauce
Conjugated
linoleic acids
Edible coatings, sauce
Sauce
Sauce
Sauce
Sauce
Sauce

Flavonoids, vitamins

Conjugated
Conjugatedlinoleic
linoleicacids
acids
Conjugated linoleic acids
ω-3
ω-3fatty
fattyacids
acids

3. Factors Limiting the Bioavailability of Bioactive Compounds
3. Factors Limiting the Bioavailability of Bioactive Compounds
There are several factors that limit the oral bioavailability of bioactive compounds in foods.
There
several
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thefate
oralofbioavailability
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There is aare
need
to better
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during
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through
is athe
need
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theoptimal
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duringtheir
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GITtoin
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integrated approach has been recently described to explain the main factors limiting the oral
bioavailability of bioactive compounds (Equation (1)) [18]:
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in order to formulate optimal excipient foods to enhance their oral bioavailability. An integrated
approach has been recently described to explain the main factors limiting the oral bioavailability of
bioactive compounds (Equation (1)) [18]:
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BA “ B* ˆ A* ˆ T*
BA = B* × A* × T*

(1)
(1)
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during digestion (Figure 2).
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oral bioavailability
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bioaccessibility;
absorption; and transformation.
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and transformation.

The classification of bioactive compounds according to the factors limiting their oral
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Table 2. Examples of potential excipient foods to be co-ingested with natural food products to enhance
the oral bioavailability of bioactive compounds.
Bioaccessibility

Absorption

Transformation

Liberation: the bioactive must be
released from the drug,
supplement of food matrix

Mucus layer: the bioactive must be
transported across the mucus layer that
coats epithelium cells

Chemical transformation: some
bioactives undergo chemical
degradation within the GIT

Solubilization: the bioactive must
be solubilized within GIT fluids

Tight junctions: some bioactives may pass
through tight junctions separating
epithelium cells

Biochemical transformation: some
bioactives are digested or
metabolized by enzymes in the GIT

Interactions: the bioactive may
interact with other food
components

Membrane permeation: some bioactives
may be transported through the
phospholipid bilayer
Active Transport: some bioactives are
transported by active transport proteins
Efflux: some bioactives are removed from
epithelium cells by efflux proteins

4. Nanoemulsions
4.1. Formation
The formation of food-grade nanoemulsions can be divided into high-energy or low-energy
methods [13,19]. High-energy approaches utilize mechanical forces to intermingle oil and
aqueous phases and to produce small droplets, and they include high-pressure homogenization,
microfluidization, and sonication [20]. Sonicators generate high intensity ultrasonic waves that break
up the oil and water phases into small droplets mainly through cavitation effects [21]. High-pressure
homogenizers and microfluidizers also generate intense disruptive forces that can break oil droplets
down to the sub-micron range [22]. Low-energy methods utilize changes in the composition or
environment of a surfactant-oil-water system to spontaneously form small droplets, and they include
spontaneous emulsification or phase-inversion methods [23]. Low-energy methods are able to produce
nanoemulsions with simple equipment and avoid the temperature increase that is caused when using
many high-energy approaches, with similar droplet size and stability characteristics. However, high
surfactant-to-oil ratios (SOR) are needed (SOR > 0.7) when using low-energy methods to obtain small
oil droplets [24], which might be a drawback to produce excipient foods containing a minimum
amount of synthetic ingredients. In fact, the excess of surfactant used to produce nanoemulsions
by low-energy methods might form micelles and cause destabilization phenomena in food products
containing larger fat droplets [25]. Therefore, it is important to select the optimal fabrication method to
obtain excipient nanoemulsions with optimal properties suitable for each type of food product that
they will be co-ingested with. In this review article, we refer to both nanoemulsions produced by
high-energy or low-energy methods.
4.2. Characteristics
The physicochemical characteristics and composition of nanoemulsions may be modulated in
order to form excipient emulsions suitable for each target application (Figure 3) [26].
4.2.1. Droplet Size
By definition the oil droplet radius in nanoemulsions is typically below 100 nm, which leads to
properties significantly different from conventional emulsions [13]. The formation conditions, such as
homogenization pressure and cycles, can be controlled to obtain different droplet sizes. Moreover, the
emulsifier type and oil phase composition used will also determine the droplet size. Nanoemulsions
containing smaller droplet sizes have been shown to be digested by lipases more rapidly than those
containing larger droplet sizes, which is attributed to a higher surface area and therefore more binding
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sites for intestinal lipases [27]. Nanoemulsions with a faster digestibility might be used for bioactive
compounds with a faster absorption pattern, where the presence of mixed micelles is required at early
Nanomaterials 2016, 6, 17
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stages of the intestinal tract; whereas excipient nanoemulsions with a larger droplet size and therefore
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Figure 3. Schematic representation of the variables that can be modulated in order to formulate excipient

Figure 3.
Schematic representation of the variables that can be modulated in order to
nanoemulsions to enhance the oral bioavailability of naturally-occurring bioactive compounds.
formulate excipient nanoemulsions to enhance the oral bioavailability of naturally-occurring
bioactive
compounds.
4.2.2. Droplet
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other oil droplets or with other charged food compounds. Consequently, it influences the aggregation
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state of the lipid droplets (stable, flocculated or coalesced), which alters the exposed surface area where
digestive enzymes adsorb. Moreover, the nature of the interface will influence the ability of bile salts
and digestive enzymes to adsorb to the lipid droplet surfaces and initiate lipolysis [30]. Moreover,
the surfactants and emulsifiers used to formulate nanoemulsions may also have an impact on the
solubilization capacity of bioactive compounds in the intestinal juices. Consequently, the selection of
an appropriate emulsifier must be optimized to ensure good bioaccessibility.
4.3. Mechanisms of Action
The design of nanoemulsions can be optimized to enhance the oral bioavailability of bioactive
compounds in the GIT altering their compositions or structures. In this section, we highlight
how discuss excipient nanoemulsions can be designed to alter the bioaccessibility, absorption, or
transformation of bioactive compounds.
4.3.1. Bioaccessibility
The bioaccessibility is defined as the amount of a bioactive agent that is present within the
gastrointestinal tract in a form suitable for absorption (mB ) compared to the total amount ingested
(mTotal ) (Equation (2)):
B* “ 100 ˆ mB {mTotal
(2)
In the case of lipophilic bioactive compounds, the fraction of bioactive compound that is
solubilized in the micelle phase after the small intestine phase is considered to be potentially absorbable.
There are several strategies that can be used to increase bioaccessibility by formulating nanoemulsions,
mainly divided in efforts towards a higher release from the food matrix or a higher solubilization in
the intestinal juices.
Changes in the Bioactive Release from the Food Matrix
Depending on the type of food product, bioactives may be rapidly released from the food matrix
during digestion, or they by fully or partially retained. In solid foods, mastication may facilitate the
release of a significant fraction of bioactives. Indeed, an increase in carotenoid bioaccessibility has been
reported after mastication of mangoes [31]. However this release is not always complete and there may
still be a significant part of bioactive compounds trapped in the food matrix. Moreover, in the case of
liquid products (such as tomato juice or orange juice) the passage through the mouth is very fast and
therefore the liberation of the bioactives from the plant tissue is very low. In this sense, nanoemulsions
may present an effective way to facilitate the release of hydrophobic bioactive compounds into their
oil phase during the mouth and stomach phases, that in turn might act as reservoirs of bioactives in
the intestine. For instance, there is evidence that the addition of a nanoemulsion to curcumin powder
increases the bioaccessibility [32]. The addition of ingredients to an excipient nanoemulsion that favor
the dissociation of plant materials may also favor the release of bioactive compounds. For instance,
chelating agents might bind calcium from the plant cell wall and increase its permeability and therefore
increase the release of bioactive compounds. Also, the incorporation of proteins in the formulation of
nanoemulsions might decrease the intestinal pH due to their high buffering capacity [33]. Changes in
the pH in the intestinal phase might alter the rate and extent of the breakdown of food matrix and
therefore favor the liberation of bioactives entrapped within plant or animal tissue cells.
Solubilization in the Intestinal Fluids
The solubilization of hydrophobic bioactive compounds in the aqueous fluids within the GIT is
often an important step limiting their bioaccessibility. The co-ingestion of a lipid source has been shown
to improve the bioaccessibility of many hydrophobic bioactives by increasing their solubility in GIT
fluids [2,34,35]. This fact can be related to a number of factors that favor the solubilization of lipophilic
compounds in the GIT fluids [36]. First, the ingestion of a high amount of lipids favors the production
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of digestion enzymes and bile salts, which increases the solubilization capacity of the mixed micelle
phase. Second, the ingestion of foods with high fat levels slows down GIT transit, thereby increasing
the time for bioactives to be released from food matrices, solubilized, and absorbed [37]. Third, the
release of free fatty acids and monoacylglycerols from the initial triglyceride structure contributes to the
formation of mixed micelles that increase the solubilization capacity of the GIT fluids for hydrophobic
Nanomaterials 2016, 6, 17
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bioactives. Finally, the use of food-grade surfactants in excipient nanoemulsions can also increase
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barriers that the bioactive components must overcome. The absorption of a bioactive compound is
amount in the gastrointestinal tract (mTotal ) (Equation (3)):
the amount that is bioaccessible and transferred into the epithelium cells (mBA) compared to the total
amount in the gastrointestinal tract (mTotal) (Equation (3)):

B* “ 100 ˆ mBA {mTotal
B* = 100 × mBA/mTotal

(3)

Figure 4. Schematic representation of the mechanisms involved in the absorption of bioactive

Figure 4. Schematic representation of the mechanisms involved in the absorption of bioactive
compounds in the gastrointestinal tract. The absorption of bioactive agents may be limited due to
compounds in the gastrointestinal tract. The absorption of bioactive agents may be limited due
their transport across the epithelium cell through passive, active or efflux mechanisms. Most bioactive
to their
transport across the epithelium cell through passive, active or efflux mechanisms. Most
compounds are usually absorbed in the upper gastrointestinal tract (GIT) and therefore do not reach
bioactive
compounds
are usually
absorbed
in the upper
gastrointestinal
and therefore
the M-cells,
but bioactives
trapped
within indigestible
particles
or matricestract
may (GIT)
move further
down do
not reach
the
M-cells,
but
bioactives
trapped
within
indigestible
particles
or
matrices
may
move
further
the GIT and then encounter the M-cells.
down the GIT and then encounter the M-cells.
Increase in Mucus Layer Transport

The mucus layer is a porous hydrogel layer that coats the enterocytes in the epithelium cells. For
the bioactive compound to be transferred to the intestinal cells it has to travel across the mucus layer.
If the mixed micelles are larger than the pore size (400 nm) or strongly interact with the mucus layer,

(3)
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Increase in Mucus Layer Transport
The mucus layer is a porous hydrogel layer that coats the enterocytes in the epithelium cells.
For the bioactive compound to be transferred to the intestinal cells it has to travel across the mucus layer.
If the mixed micelles are larger than the pore size (400 nm) or strongly interact with the mucus layer,
then their transport through this layer might be significantly inhibited. For instance, nanoemulsions
can be formulated with small molecule surfactants or other stabilizers that help forming small mixed
micelles that easily penetrate through the mucus layer [41].
Increase in the Permeability of Cell Membranes
Once the bioactive has passed through the mucus layer, it may be incorporated into the intestinal
cells by either passive or active transport (Figure 4). The nature and environment of the bioactive
compound determines the absorption route taken [42–44]. Sufficiently small colloidal particles may
be able to travel through the narrow channels separating the epithelial cells known as tight junctions.
Therefore, excipient nanoemulsions could be formulated with ingredients that are capable of enlarging
the tight junctions [45] such as certain surfactants [46,47]; biopolymers [48,49], mineral ions [50], and
chelating agents [51]. Other types of bioactive compounds are transported across the epithelium cell
walls by specific or non-specific protein-transporter systems, which consist of one or more proteins
embedded in the phospholipid bilayer. Both passive and active transport can be modulated by
including excipient ingredients in nanoemulsions such as piperine [52], sucrose monoesters [53], and
rhamnolipids [54].
Efflux Inhibition
After bioactive compounds are transported into the epithelium cells they may be pumped back
into the GIT by certain efflux transporters located in the cell membranes [55,56]. Certain food
ingredients might block the efflux transporters, such as quercetin, resveratrol, and piperine that
may act as efflux inhibitors for certain pharmaceutical agents [57–60]. Efflux inhibitors might either
block binding sites on the surfaces of efflux proteins, interfere with the energy production mechanism
required for efflux or change cell membrane structure thereby altering the conformation and activity
of efflux proteins.
4.3.3. Transformation
Many bioactive compounds undergo chemical or enzymatic transformations during their passage
though the GIT, which may alter their bioavailability and bioactivity. These transformations may be
from an active to an inactive form, or vice versa. For instance, carotenoids are present in different
isomer forms in fruits and vegetables, and cis-isomers are more bioavailable than trans-isomers since
the long linear structure of trans-isomers are difficult to fit into mixed micelles [61,62]. Trans-isomers in
foods can undergo isomerization to cis-isomers, which might then be absorbed more effectively [63,64].
Consequently, it may be possible to add excipient ingredients to a nanoemulsion to enhance this
isomerization reaction. Conversely, certain types of food components under oxidation or other
degradation reactions that reduce their biological activity, e.g., carotenoids, ω-3 fatty acids, and
curcumin. In these cases, it is possible to add natural or synthetic antioxidants to inhibit their
degradation [65]. Therefore, efforts might be put in designing foods that might favor or oppose
the chemical or enzymatic conversions of bioactive compounds in the GIT.
4.4. Examples of Excipient Nanoemulsions
Recently, a number of studies have demonstrated the potential application of nanoemulsions
for enhancing the oral bioavailability of bioactive compounds in natural foods (Table 3). Different
strategies have been addressed to enhance the oral bioavailability of bioactive compounds though
increasing the bioaccessibility, the absorption, or transformation.
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Table 3. Examples of potential excipient emulsions or nanoemulsions to be co-ingested with natural
food products to enhance the oral bioavailability of bioactive compounds.
Emulsion

Nutraceuticals

Corn oil emulsions

Curcumin in
Powdered Form

Corn oil emulsions

Curcumin in
Powdered Form

Corn oil emulsions

Curcumin in
Powdered Form

Corn oil, medium chain
triglycerides or orange
oil emulsions

Carotenoids in
yellow peppers

Olive oil emulsions
Peanut oil emulsions
Various emulsions

Carotenoids in
Carrot and Tomato
suspensions
Carotenoids in
Tomato juice
Carotenoids in
vegetables and salads

Excipient Emulsion Influencing
Nutraceuticals Bioaccessibility
The solubility and bioaccessibility of curcumin
was significantly improved by incubating and
co-ingesting with excipient emulsion.
Emulsifier type and droplet size of exhibited a
significant effect on the solubility and
bioaccessibility of curcumin.
The bioaccessibility of curcumin depended on
oil type and concentration.
Increased carotenoid bioacessibility from
yellow peppers when consumed with corn oil
nanoemulsions as excipient emulsions.
Adding olive emulsions to carrot and tomato
suspensions increased carotenoid uptake in the
micellar phase.
Lycopene bioaccessibility was dependent on
emulsification and emulsifier type
Addition of oil to salads and vegetables
increased lycopene bioaccessibility depending
on fatty acid type

Reference

[32]

[66]
[67]
[68]

[69]
[70]
[71,72]

4.4.1. Increase in Bioaccessibility
For powdered nutraceuticals, nanoemulsions have been shown to significantly increase the
transfer of the bioactive crystalline form to the oil phase, which is directly related to an increased
solubility in the GIT fluids. For instance, Zou and co-workers [32,66] reported an increased in vitro
bioaccessibility of powdered curcumin after mixing with excipient nanoemulsions, which simulated a
salad dressing (incubation at 30 ˝ C) or a cooking sauce (incubation at 100 ˝ C). They found a higher
transfer of curcumin powder to the oil droplets when nanoemulsions were incubated at 100 ˝ C
compared to 30 ˝ C. In the case of bioactive compounds in plant-based products, lipid droplets in
nanoemulsions lipid droplets may act as a non-polar solvent that facilitates the liberation of the
hydrophobic bioactives from their original location in plant tissues [70]. In fact, the results from several
studies with different vegetables are consistent and support this statement. For example, an increase
in carotenoid bioaccessibility from yellow peppers has been found after being mixed with excipient
nanoemulsions [68]. Moreover, the solubilization of carotenoids in the micelle fraction after in vitro
digestion of carrot and tomato suspensions was significantly increased after being co-ingested with
olive oil emulsions.
There are several factors that influence the ability of excipient nanoemulsions to enhance the
bioaccessibility of bioactive compounds, such as the lipid amount, size and composition. For instance,
it is known that the higher the oil concentration in the formulation of bioactive-loaded nanoemulsions,
the higher the bioaccessibility [29]. This behavior also occurs with excipient nanoemulsions or
emulsions consumed with bioactive-rich foods. It has been reported that full-fat salad dressings
enhance the oral bioavailability of bioactive compounds to a higher extent than low-fat dressings [17].
Also, the oil composition influences the solubilization of hydrophilic nutraceuticals in the intestinal
juices, since the free fatty acids will form the non-polar domains of the mixed micelle phase. It is
known that nanoemulsions formulated with long chain triglycerides show an enhanced bioaccessibility
of hydrophobic bioactives than medium or short chain triglycerides, which is attributed to a
larger micelle structure able to accommodate the hydrophobic bioactives in their core [28,29]. This
phenomenon is important when designing excipient nanoemulsions since the same principle would
apply for nanoemulsions that are co-ingested with natural foods, as the bioactive compounds
might already be transferred into the oil phase prior to digestion. Moreover, the nanoemulsion
droplet size is an important factor that determines the rate of lipid digestion rate and mixed
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micelle formation. The smaller the droplet size, the higher the lipid hydrolysis rate and in turn
the higher the bioaccessibility [14,73]. This behavior has been also detected when designing excipient
nanoemulsions [66].
The ability of nanoemulsions to enhance the solubilization of lipophilic bioactive compounds
in intestinal juices has been demonstrated for numerous types of hydrophobic bioactive agents.
Nevertheless, the overall bioavailability of the solubilized fraction has been studied far less
frequently. Even so, some studies have shown that hydrophobic bioactive compounds encapsulated
within nanoemulsions have a higher bioavailability than those encapsulated within conventional
emulsions [74]. On the other hand, to the best of the authors’ knowledge, there have been no reports
on the improvement of the bioavailability of bioactive compounds using excipient nanoemulsions to
date. Therefore, it is important to elucidate the potential efficacy of excipient nanoemulsions using
animal and human feeding studies.
4.4.2. Changes in Absorption and Transformation
Strategies developed to enhance the absorption or transformation of bioactive compounds in the
gastrointestinal tract using excipient nanoemulsions is currently scarce, but it is certainly an important
topic that should be studied more to improve the ability of excipient nanoemulsions to boost the
oral bioavailability of bioactive compounds. For instance, it is known that oil type influences the
absorption of bioactives in the gastrointestinal tract as they influence the nature of the chylomicrons
formed [75,76]. Oleic acid has also been shown to be an effective inhibitor of efflux mechanisms [77],
which may help increase the absorption of certain bioactive compounds. Moreover, the intestinal
absorption of hydrophobic bioactives has been enhanced by their ingestion along with piperine from
black pepper, which alters the epithelium cell transport mechanisms [78]. Regarding the molecular
and structural transformation of bioactive compounds during their passage though the intestinal
tract, efforts have been made to design structures to protect them from oxidation and degradation.
For instance, the presence of chelating agents, such as EDTA, or antioxidants, such as tocopherol, has
shown to decrease the degradation rate of astaxanthin [79]. This would also be valid for the design
of excipient nanoemulsions, which might contain those ingredients either in the aqueous or lipid
phases and would protect the natural bioactive compounds in foods. The type of antioxidant used to
formulate excipient nanoemulsions might be specifically selected depending on the type of bioactive
compound to be protected. For instance, lipophilic bioactive compounds such as tocopherols can be
included in the lipid phase to prevent degradation of carotenoids. On the other hand, chelating agents
(such as EDTA) can be incorporated into the aqueous phase to bind with and inactivate pro-oxidant
metal ions (such as iron). Thus, even though the current knowledge regarding the exact mechanism
about how to improve the oral bioavailability of different natural bioactives in food is still to be fully
elucidated, the available information clearly highlights the greater potential of nanoemulsions as
excipient foods.
5. Conclusions
In this review article we focused on describing the potential advantages of using nanoemulsions
as excipient foods to increase the oral bioavailability of naturally occurring bioactive compounds. It is
important to understand the fate of health-related food components in the gastrointestinal tract so as
to formulate nanoemulsions with specific structures and compositions known to boost bioavailability
and maintain bioactivity. Excipient nanoemulsions may be used to enhance the bioaccessibility
and absorption of bioactive compounds in the gastrointestinal tract, as well as controlling their
molecular form to ensure they are in the most bioactive state. In certain applications, nanoemulsions
have advantages over conventional emulsions because their small droplet size and higher surface
area leads to rapid digestion and mixed micelle formation. The co-ingestion of nanoemulsions
with foods, supplements or drugs may be a useful method to optimize the uptake of hydrophobic
bioactives. Nevertheless, there is still a need to unravel the complex physicochemical and physiological
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processes involved when excipient nanoemulsions and foods pass through the GIT. This information
might be highly valuable for the food and pharmaceutical sector to optimize the bioavailability of
bioactive compounds.
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